Skip to content

Our GMP-ready pharmaceutical 3D printers have patent-protected in-built quality control and exchangeable printhead systems for technology versatility, quality assurance and easy cleaning. We also provide advanced control software, formulation development services and consultation with our world leading scientists for all of your pharmaceutical 3D printing needs.

FABRX carried out the world’s first clinical study for 3D printed personalised medicine in 2018 and launched their first printer, the M3DIMAKER 1 in 2020. They have since launched their 3-printhead M3DIMAKER 2 pharmaceutical 3D printer and are involved in several more clinical studies worldwide. FABRX collaborates with universities, pharmacies, hospitals and pharmaceutical companies around the world to make this exciting new technology a reality, developing new pharma-inks (preprinted formulation) for personalised medicine and implementing 3D printing into clinical trial work flows for improved efficiency. Get in touch now!

For more informatin, please visit: https://www.fabrx.co.uk

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.